BioNTech SE is 12.9x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($21.79 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | BNTX |
|---|---|---|
| Market cap | $1.69 B | $21.79 B |
| US-listed rank | #2235 | #587 |
| Revenue (latest FY) | $263.50M | - |
| Net income (latest FY) | -$391.00M | - |
| Net margin | -148.4% | - |
| SEC filings | 1,005 | 548 |
BioNTech SE is 12.9x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($21.79 B vs $1.69 B).
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and BioNTech SE, or browse the full rankings.